Impact of myo-inositol treatment in women with polycystic ovary syndrome in assisted reproductive technologies

• Main Authors: Philippe Merviel (Author), Pandora James (Author), Sarah Bouée (Author), Mathilde Le Guillou (Author), Camille Rince (Author), Charlotte Nachtergaele (Author), Véronique Kerlan (Author)
• Format: Book
• Published: BMC, 2021-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Polycystic ovary syndrome (PCOS) is marked in 30 to 40% by insulin resistance and hyperandrogenism. Myo-inositol (MI) increases insulin sensitivity, decreases hyperandrogenism and improves the menstrual cycle. Its effect during assisted reproductive technologies (ART) has been studied by ma...